Menu

A Dire Air Pollution Warning

Contaminants in the air are officially carcinogens, according to the World Health Organization.

Oct 21, 2013
Bob Grant

WIKIMEDIA, NATIONAL PARKS SERVICEAir pollution—from vehicle exhaust, industry, and large fires—can cause lung cancer, according to a new report from the World Health Organization’s cancer arm, the International Agency for Research on Cancer (IARC). The announcement marks the first time that outdoor air pollution has been officially classified as a carcinogen. “This report should send a strong signal to the international community to take action,” IARC director Christopher Wild told Bloomberg. “We can’t treat our way out of this cancer problem. The first step is identifying the causes.”

Outdoor air pollution caused about 223,000 deaths from lung cancer around the world in 2010, according to the report, which reviewed published studies to reach the conclusion that pollutants in air could be deadly. Rather than focusing on particular components of air pollution, the IARC examined health data relating to fouled air in general. “Our task was to evaluate the air everyone breathes rather than focus on specific air pollutants,” Dana Loomis, an IARC official that participated in compiling the report, told The Guardian. “The results from the reviewed studies point in the same direction: the risk of developing lung cancer is significantly increased in people exposed to air pollution.” The report also notes that air pollution can be linked to bladder cancer.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.